Ian R. Hardy

697 total citations
10 papers, 556 citations indexed

About

Ian R. Hardy is a scholar working on Oncology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ian R. Hardy has authored 10 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Biomedical Engineering and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ian R. Hardy's work include CAR-T cell therapy research (7 papers), Nanowire Synthesis and Applications (3 papers) and Immune Cell Function and Interaction (3 papers). Ian R. Hardy is often cited by papers focused on CAR-T cell therapy research (7 papers), Nanowire Synthesis and Applications (3 papers) and Immune Cell Function and Interaction (3 papers). Ian R. Hardy collaborates with scholars based in United States, Germany and Switzerland. Ian R. Hardy's co-authors include Ashley K. Woods, Travis S. Young, Eric Hampton, Vanessa Núñez, Nitya S. Ramadoss, Yu Cao, Feng Wang, Oded Singer, Jiayin Shen and Peter G. Schultz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Ian R. Hardy

10 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian R. Hardy United States	7	423	241	185	161	104	10	556
Kathleen Gallagher United States	12	633 1.5×	212 0.9×	196 1.1×	195 1.2×	151 1.5×	32	837
Danielle Vanasse United States	6	507 1.2×	158 0.7×	189 1.0×	135 0.8×	142 1.4×	7	549
Mohamed-Reda Benmebarek Germany	9	594 1.4×	190 0.8×	213 1.2×	259 1.6×	148 1.4×	17	686
Stefanie Lesch Germany	8	686 1.6×	211 0.9×	284 1.5×	278 1.7×	188 1.8×	10	798
Lori McIntyre United States	5	641 1.5×	220 0.9×	173 0.9×	194 1.2×	179 1.7×	8	700
Erik F. Williams United States	3	388 0.9×	105 0.4×	170 0.9×	224 1.4×	76 0.7×	4	556
Parisa Malekzadeh United States	7	651 1.5×	150 0.6×	196 1.1×	377 2.3×	101 1.0×	14	795
Jennifer Ma United States	10	390 0.9×	235 1.0×	247 1.3×	129 0.8×	91 0.9×	13	639
Elizabeth Halton United States	14	555 1.3×	141 0.6×	117 0.6×	129 0.8×	187 1.8×	29	604
Simon Thomas United Kingdom	10	677 1.6×	266 1.1×	279 1.5×	201 1.2×	215 2.1×	28	773

Countries citing papers authored by Ian R. Hardy

Since Specialization

Citations

This map shows the geographic impact of Ian R. Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Hardy more than expected).

Fields of papers citing papers by Ian R. Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Hardy. The network helps show where Ian R. Hardy may publish in the future.

Co-authorship network of co-authors of Ian R. Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Hardy. A scholar is included among the top collaborators of Ian R. Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Hardy. Ian R. Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fischer, Laura, P.R. Maul, Arina Riabinska, et al.. (2024). Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system. Frontiers in Immunology. 15. 1483254–1483254. 3 indexed citations

Wemlinger, Scott M., Chelsea R. Parker Harp, Bo Yu, et al.. (2022). Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. The Journal of Immunology. 208(7). 1566–1584. 8 indexed citations

Hardy, Ian R., Wolfgang W. Schamel, Patrick A. Baeuerle, Daniel R. Getts, & Robert Hofmeister. (2020). Implications of T Cell Receptor Biology on the Development of New T Cell Therapies for Cancer. Immunotherapy. 12(1). 89–103. 7 indexed citations

Viaud, Sophie, S. Y. Jennifer, Ian R. Hardy, et al.. (2018). Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences. 115(46). E10898–E10906. 73 indexed citations

Clarke, Raedun, Tom Lee, Jorge Mansilla‐Soto, et al.. (2018). Abstract LB-108: Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy. Cancer Research. 78(13_Supplement). LB–108. 9 indexed citations

Bjordahl, Ryan, Raedun Clarke, Svetlana Gaidarova, et al.. (2017). Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy. Blood. 130. 3187–3187. 1 indexed citations

Rodgers, David T., Magdalena Mazagova, Eric Hampton, et al.. (2016). Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences. 113(4). E459–68. 317 indexed citations

Hardy, Ian R., Nadia Anceriz, François Rousseau, et al.. (2014). Anti-CD79 Antibody Induces B Cell Anergy That Protects against Autoimmunity. The Journal of Immunology. 192(4). 1641–1650. 32 indexed citations

O’Brien, Rebecca L., M. Kemal Aydintug, Yafei Huang, et al.. (2011). αβ TCR⁺T Cells, but Not B Cells, Promote Autoimmune Keratitis in B10 Mice Lacking γδ T Cells. Investigative Ophthalmology & Visual Science. 53(1). 301–301. 5 indexed citations

10.

Young, Ryan M., Ian R. Hardy, Raedun Clarke, et al.. (2008). Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood. 113(11). 2508–2516. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact